Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Arch Oncology

Arch Oncology

Antibody Therapies

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
CEO
‌
Laurence Blumberg
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...oncology
Email Address
info@archoncology.com
Full Address
2000 Sierra Point Pkwy, Brisbane, California 94005, US
Industry
Cancer immunotherapy
Cancer immunotherapy
Immunotherapy
Immunotherapy
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Medicine
Medicine
Internal medicine
Internal medicine
Biopharmaceutical
Biopharmaceutical
Cancer
Cancer
Diagnosis
Diagnosis
Healthcare
Healthcare
•••
Invested in
Roche Venture Fund
Roche Venture Fund
Investors
LightChain
LightChain
Roche Venture Fund
Roche Venture Fund
RiverVest Venture Partners
RiverVest Venture Partners
Missouri Technology Corporation
Missouri Technology Corporation
0
Rodger O. Riney
Rodger O. Riney
Latest Funding Round Date
May 24, 2021
Latest Funding Round Amount (USD)
105,000,000
Latest Funding Type
Series C
Series C
LinkedIn URL
@company/archoncology
Location
Brisbane, California
Brisbane, California
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles.../56258-65
Public/Private
Private
Total Funding Amount (USD)
260,000,000
Official Website
archoncology.com

Find more companies like Arch Oncology

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.